Search

everythinglearnresearchcommunity

for

Search:↓

Targeting the protein Caveolin-1 might help treat a type of scarring hair loss called Frontal Fibrosing Alopecia.

Oxidative stress may contribute to hair loss in alopecia areata and antioxidants could potentially help as a treatment.

ILC1 cells contribute to hair loss in alopecia areata.

Regulatory γδ T cells help protect hair follicles from alopecia areata and promote hair regrowth.

ILC1-like cells can independently cause alopecia areata by affecting hair follicles.

The new aptamer TAGX-0003 shows promise as an effective treatment for hair loss disorder alopecia areata.

Innate lymphoid cells type 1 may contribute to alopecia areata.

The conference highlighted new diagnostic tools, the role of genetics in hair loss, and emerging treatments.

New treatments targeting T-cell pathways are needed for better alopecia areata management.

Alopecia areata is an autoimmune disease where T cells attack hair follicles.

Lichen Planopilaris and Frontal Fibrosing Alopecia may help us understand hair follicle stem cell disorders and suggest new treatments.

Alopecia areata, a type of hair loss, is likely an autoimmune disease with a genetic link, but its exact cause is still unknown.

ILC1-like cells can cause alopecia areata by disrupting hair follicle immunity, suggesting a new treatment approach.

Stress hormones and autoimmune reactions can cause hair loss.

Human dermal γδT-cells respond to stress in hair follicles, contributing to hair loss.

Sorafenib may cause hair loss in a way similar to alopecia areata.

AIRE deficiency causes hair loss similar to alopecia areata in mice.

Vδ1+ T-cells in the skin contribute to hair loss in alopecia areata and could be targeted for treatment.

ILC1-like cells can cause alopecia areata by attacking hair follicles.

New treatments for alopecia areata show promise, but standardized guidelines are needed.

Alopecia Areata is an autoimmune condition causing hair loss with no cure and treatments that often don't work well.

Treg cell-based therapies might help treat hair loss from alopecia areata, but more research is needed to confirm safety and effectiveness.

The study found that a key immune pathway protecting hair follicles is reduced in a mouse model of scarring hair loss.

Immune cells are crucial for hair growth and preventing hair loss.

Alopecia areata is likely an autoimmune disease with unclear triggers, involving various immune cells and molecules, and currently has no cure.

Immune cells around hair follicles help control hair growth and could be targets for treating hair disorders.

New treatments for child hair loss due to immune issues are effective but not yet officially approved.

The document concludes that the immune-inhibitory environment of the hair follicle may prevent melanoma development.

The review suggests that other immune cells besides CD8+ T cells may contribute to alopecia areata and that targeting regulatory cell defects could improve treatment.

EGCG may help treat alopecia areata by blocking certain immune responses and reducing specific harmful immune cells.